Aneliya Knauthe

Study-design, planning, submitting and conducting clinical performance studies to verify and validate in-vitro diagnostic tools (accroding to IVDR, MPDG, ISO 9001:2015 and ISO 20916:2019).

• Phase I-III trials in Germany, Austria and Bulgaria • Visits: Site Selection, Site Initiation, Interim Monitoring, Remote, Motivational, Close-Out • site training, SDV, query resolution, drug accountability, site files, TMF, CTMS • site feasibility, start up activities, submissions, contract negotiations • translator at FDA inspection Indications: Oncology, Haematology, Gynaecology, Endocrinology, Immunology, Nephrology, Autoimmune Diseases, Paediatrics and Rare Diseases

Investigated cell cultures and samples on gene, RNA and protein level Processed large amounts of data

Analyzed samples on gene level

Conducted functional genetics experiments

Traded with medical and laboratory equipment and products Customer service demeanour and data management Documented invoices, contracts and customers data base Prepared the annual business fair Translated technical descriptions

Documented invoices, contracts and customers data base Customer service demeanour and data management Prepared the annual business fair Translated invoices, purchase orders and technical descriptions

Implement surveys and inquired about social and customer habits Maintained contact with former clients

Master thesis: “Natural compounds and their derivatives as modulators of Wnt/ß-catenin signaling” Highlights: Clinical Chemistry and Molecular Diagnostics, Medical Biometry, Molecular Pathology, Molecular Pharmacology, German, Russian

Experiment Design and Analysis, Foundations of Biotechnological Industries, Organic Chemistry, Biochemistry, Molecular Biology, Biophysics and Radiobiology, Microbiology, Virology